Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER × Tislelizumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 570 Prostatic Neoplasms 335 Neoplasms 279 Carcinoma, Non-Small-Cell Lung 200 Lung Neoplasms 175 Colorectal Neoplasms 160 Pancreatic Neoplasms 130 Multiple Myeloma 130 Leukemia, Myeloid, Acute 117 Neoplasm Metastasis 115 Brain Neoplasms 114 Melanoma 108 Ovarian Neoplasms 97 Precursor Cell Lymphoblastic Leukemia-Lymphoma 96 Glioblastoma 96 Head and Neck Neoplasms 90 Squamous Cell Carcinoma of Head and Neck 87 Carcinoma, Hepatocellular 87 Recurrence 81 Colonic Neoplasms 77 Uterine Cervical Neoplasms 75 Lymphoma 71 Stomach Neoplasms 70 Rectal Neoplasms 70 Sarcoma 69 Triple Negative Breast Neoplasms 65 Hematologic Neoplasms 64 Urinary Bladder Neoplasms 62 Myelodysplastic Syndromes 62 Lymphoma, Non-Hodgkin 62

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04906044 2023-11-18

STARS-RC03

The First Hospital of Jilin University

Phase 1 Active not recruiting

Gastrointestinal

Tislelizumab

Data powered by HemOnc (CC BY 4.0) Colophon ⚡